(By Balaseshan) Medical devices maker Becton, Dickinson and Co. (NYSE: BDX) said it has closed its acquisition of California-based privately-held Safety Syringes Inc., which specializes in the development of anti-needlestick devices for prefilled syringes, for undisclosed sum.
The company expects the transaction to be minimally dilutive for fiscal year 2013, and does not expect it to impact BD's previously communicated 2013 earnings guidance.
The acquisition broadens BD's healthcare worker safety offering to include passive safety technologies for any prefillable syringe customer.
"We believe the Safety Syringes product line is a valuable asset to BD and aligns well with our focus on healthcare worker safety, and offering higher-value products. We are excited about this acquisition, which expands its presence in safety technologies and further demonstrates BD's commitment to developing innovative solutions that help address our customers' unmet needs," said Claude Dartiguelongue, President, BD Medical - Pharmaceutical Systems.
[Related -3 Styles Of Successful Dividend Investing]
BD is a global medical technology company engaged in the development, manufacture and sale of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, pharmaceutical industry and general public. Its operations consist of 3 business segments: BD Medical, BD Diagnostics and BD Biosciences.
BDX is trading down 0.43% at $78.22 on Wednesday. The stock has been trading between $71.56 and $80.56 for the past 52 weeks.